Neuralink's N1 device aims to restore mobility and vision, presenting significant medical potential. Neuralink is privately held, not publicly traded, limiting direct investment opportunities.
Mistral AI raised $113 million in seed funding, totaling a $6 billion valuation after further rounds. Mistral AI specializes in developing open-source large language models like AI chat and coding ...